Intrexon | XON - Ação





Ação Alterar Data
Amgen USD 6.22B 121M 2025-12
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
AstraZeneca USD 6.59B 126M 2025-09
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Incyte USD 101.06M 17.61M 2025-12
Intrexon USD 287K 68K 2022-12
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
MacroGenics USD 7.91M 840K 2025-12
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Thermo Fisher Scientific USD 5.43B 320M 2025-12
Veracyte USD 20.55M 219K 2025-12